The interaction of factor V and tissue factor pathway inhibitor in a myeloma patient with acquired factor V deficiency
2018; Wiley; Volume: 24; Issue: 3 Linguagem: Inglês
10.1111/hae.13492
ISSN1365-2516
AutoresEmilie De Maertelaere, Elisabetta Castoldi, Inge Van Haute, Dries Deeren, Katrien Devreese,
Tópico(s)Coagulation, Bradykinin, Polyphosphates, and Angioedema
ResumoHaemophiliaVolume 24, Issue 3 p. e160-e163 LETTER TO THE EDITOR The interaction of factor V and tissue factor pathway inhibitor in a myeloma patient with acquired factor V deficiency E. De Maertelaere, Corresponding Author E. De Maertelaere emilie.demaertelaere@ugent.be orcid.org/0000-0002-7997-7302 Clinical Laboratory, AZ Delta Hospital, Roeselare, Belgium Correspondence Emilie De Maertelaere, Clinical Laboratory, AZ Delta Hospital, Roeselare, Belgium. Email: emilie.demaertelaere@ugent.beSearch for more papers by this authorE. Castoldi, E. Castoldi Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the NetherlandsSearch for more papers by this authorI. Van haute, I. Van haute Clinical Laboratory, AZ Delta Hospital, Roeselare, BelgiumSearch for more papers by this authorD. Deeren, D. Deeren Clinical Haematology, AZ Delta Hospital, Roeselare, BelgiumSearch for more papers by this authorK. M. Devreese, K. M. Devreese Coagulation Laboratory, Department of Clinical Chemistry, Microbiology and Immunology, Ghent University Hospital, Ghent, BelgiumSearch for more papers by this author E. De Maertelaere, Corresponding Author E. De Maertelaere emilie.demaertelaere@ugent.be orcid.org/0000-0002-7997-7302 Clinical Laboratory, AZ Delta Hospital, Roeselare, Belgium Correspondence Emilie De Maertelaere, Clinical Laboratory, AZ Delta Hospital, Roeselare, Belgium. Email: emilie.demaertelaere@ugent.beSearch for more papers by this authorE. Castoldi, E. Castoldi Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the NetherlandsSearch for more papers by this authorI. Van haute, I. Van haute Clinical Laboratory, AZ Delta Hospital, Roeselare, BelgiumSearch for more papers by this authorD. Deeren, D. Deeren Clinical Haematology, AZ Delta Hospital, Roeselare, BelgiumSearch for more papers by this authorK. M. Devreese, K. M. Devreese Coagulation Laboratory, Department of Clinical Chemistry, Microbiology and Immunology, Ghent University Hospital, Ghent, BelgiumSearch for more papers by this author First published: 17 April 2018 https://doi.org/10.1111/hae.13492Citations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume24, Issue3May 2018Pages e160-e163 RelatedInformation
Referência(s)